Saegis Pharmaceuticals
Saegis Pharmaceuticals is a biotech company in Half Moon Bay, United States, founded in 1999. It has raised $30.0M across 1 round.
- Headquarters
- Half Moon Bay, California
- Employees
- 1–10
- Founded
- 1999
- Business Model
- B2B
- Website
- saegispharma.com
- Total Funding
- $30.0M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
Saegis Pharmaceuticals was a clinical-stage CNS drug discovery company that developed small molecule therapeutics for behavioral and cognitive disorders including Alzheimer's-associated dementia, mild cognitive impairment, ADHD, and schizophrenia. The company's lead candidate, SGS518, was a novel 5HT6 serotonin receptor antagonist being evaluated for Cognitive Impairment Associated with Schizophrenia (CIAS). Saegis raised a total of approximately $30 million in venture funding before being acquired by Danish pharmaceutical company Lundbeck in 2006, which continued development of its CNS pipeline assets.
Summary
It lists 1–10 employees. It has raised $30.0M in total across 1 round. Investors include Versant Ventures, Technology Partners and Polaris Partners.
Funding History
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/saegis-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/saegis-pharmaceuticals" alt="Saegis Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>